Cited by 40Inflammatory Bowel DiseaseProtease and Inhibitor MechanismsAutoimmune and Inflammatory Disorders

Epithelial production of elastase is increased in inflammatory bowel disease and causes mucosal inflammation

Open access
Motta, Jean-Paul, Rolland, Corinne, Edir, Anissa, Florence, Ana-Carolina, Sagnat, David, Bonnart, Chrystelle, Rousset, Perrine, Guiraud, Laura +9 more·2021·Mucosal Immunology

Abstract

Imbalance between proteases and their inhibitors plays a crucial role in the development of Inflammatory Bowel Diseases (IBD). Increased elastolytic activity is observed in the colon of patients suffering from IBD. Here, we aimed at identifying the players involved in elastolytic hyperactivity associated with IBD and their contribution to the disease. We revealed that epithelial cells are a major source of elastolytic activity in healthy human colonic tissues and this activity is greatly increased in IBD patients, both in diseased and distant sites of inflammation. This study identified a previously unrevealed production of elastase 2A (ELA2A) by colonic epithelial cells, which was enhanced in IBD patients. We demonstrated that ELA2A hyperactivity is sufficient to lead to a leaky epithelial barrier. Epithelial ELA2A hyperactivity also modified the cytokine gene expression profile with an increase of pro-inflammatory cytokine transcripts, while reducing the expression of pro-resolving and repair factor genes. ELA2A thus appears as a novel actor produced by intestinal epithelial cells, which can drive inflammation and loss of barrier function, two essentials pathophysiological hallmarks of IBD. Targeting ELA2A hyperactivity should thus be considered as a potential target for IBD treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41385-021-00375-w

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Elastase 2A is enhanced in inflammatory bowel disease patients.

    “The same study specifically identified elastase 2A (ELA2A) as enhanced in IBD patients.”
  • Colonic epithelial cells are a major source of elastase-like activity and this activity is markedly increased in inflammatory bowel disease patients.

    “Motta et al.29 showed that colonic epithelial cells are a major source of elastase-like activity and this activity is markedly increased in IBD patients.”
  • Host proteases such as chymase or ELA2A are able to cleave tight and adherens junction proteins including zonula occludens-1 or E-cadherin.

    “Host proteases such as chymase or ELA2A are able to cleave tight and adherens junction proteins including zonula occludens-1 or E-cadherin.22,29,130”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Motta, J.-P., Rolland, C., Edir, A., Florence, A.-C., Sagnat, D., Bonnart, C., Rousset, P., Guiraud, L., Quaranta-Nicaise, M., Mas, E., Bonnet, D., Verdu, E. F., McKay, D. M., Buscail, E., Alric, L., Vergnolle, N., & Deraison, C.
Affiliations
  • Université Toulouse III - Paul Sabatier (FR)
  • Centre Hospitalier Universitaire de Toulouse (FR)
  • McMaster University (CA)
  • University of Calgary (CA)
Corresponding author
Vergnolle, Nathalie
Venue
Mucosal Immunology
Publisher
Elsevier BV
Published
2021-05
Volume
14
Issue
3
Pages
667-678
ISSN
1933-0219 (ISSN-L)
OpenAlex
W3133688564
Cited by
40
References
47
Citations by year
2026: 10 · 2025: 9 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 4
FWCI
2.97
Type
journal article
Language
en
Open access
Locations
  • Mucosal Immunology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by)
Funders
  • Crohn's and Colitis Foundation of Canada
  • European Commission (627487)
  • Agence Nationale de la Recherche (ANR-12-BSV1-0030, ANR-12, ANR-11-EQPX-0003)
  • Centre National de la Recherche Scientifique
  • Crohn's and Colitis Canada (623780)
  • FP7 Ideas: European Research Council (310973)
  • CHIST-ERA
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Health Sciences › Medicine › Epidemiology › Autoimmune and Inflammatory Disorders
Keywords
inflammatory bowel disease, colonic epithelial cells, elastolytic activity, epithelial barrier function, mucosal inflammation, inflammatory cytokines, cytokine gene expression
MeSH terms
Adult, Colon, Female, Humans, Inflammation, Intestinal Mucosa, Male, Middle Aged, Inflammatory Bowel Diseases, Up-Regulation, Cytokines, Inflammation Mediators, Immunity, Mucosal, Tight Junctions, Leukocyte Elastase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review